Skip Navigation
The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients
Search
Home » Advanced Search
Search Results for nevirapine
Perform Another (Advanced) Search
Related Words: nevirapine
7 Results within Entire Site
Limit results to show: Entire Site Clinical Trial Listings Newly Approved Drugs Research Center Profiles Industry Providers New Medical Results Clinical Trials Today Headlines
1. Newly Approved Drug Therapies (123) Viramune (nevirapine), Boehringer Ingelheim, ...Newly Approved Drug Therapies (123) Viramune (nevirapine), Boehringer Ingelheim, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Viramune (nevirapine) Company: Boehringer Ingelheim Approval Status: Approved June 1996 Treatment Area: HIV infection General Information Viramune ...View Page
2. Newly Approved Drug Therapies (959) Selzentry (maraviroc), Pfizer, ...of Selzentry is 150 mg twice daily. Selzentry plus other concomitant medications, including tipranavir/ritonavir, nevirapine, all NRTIs and enfuvirtide The recommended dose is 300 mg twice daily. Selzentry plus CYP3A ...View Page
3. Newly Approved Drug Therapies (645) Kaletra Capsules and Oral Solution, Abbott Laboratories, ...an ongoing, randomized, blinded, multicenter trial evaluating treatment with Kaletra at two dose levels plus nevirapine and two NRTIs. The treatment group consisted of 70 patients who had not previously taken ...View Page
4. CenterWatch: New Medical Therapies in Disease Category (179), HIV Infections ...May 5, 2003 Boehringer Ingelheim reported positive results from a post-marketing study comparing Viramune (nevirapine) to Sustiva (efavirenz) in the treatment of HIV-1 infection. Results demonstrated the efficacy of ...View Page
5. CenterWatch: New Medical Therapies in Disease Category (417), HIV ...large observational cohort study comparing anti-HIV combination treatment regimens containing Sustiva (efavirenz) or Viramune (nevirapine) in 1,078 subjects with treatment-naïve HIV showed that the Sustiva arm was significantly ...View Page
6. CenterWatch: Immunology/Infectious Diseases Approved Drug Therapies ...January 1996 Videx (didanosine) ; Bristol-Myers Squibb; Treatment of HIV infection, Approved June 1996 Viramune (nevirapine) ; Boehringer Ingelheim; Treatment for HIV infection, Approved June 1996 Vistide (cidofovir) ; Gilead; Treatment for cytomegalovirus ...View Page
7. CenterWatch: List of Newly Approved Drug Thearapies ...January 1996 Videx (didanosine) ; Bristol-Myers Squibb; Treatment of HIV infection, Approved June 1996 Viramune (nevirapine) ; Boehringer Ingelheim; Treatment for HIV infection, Approved June 1996 Vistide (cidofovir) ; Gilead; Treatment for cytomegalovirus ...View Page
Copyright © 2008 Jobson Medical Information LLC.
Designed by Piehead Productions LLC.